Data as of May 22
| -0.15 / -1.27%|
The 4 analysts offering 12-month price forecasts for Greenway Medical Technologies Inc have a median target of 14.50, with a high estimate of 16.00 and a low estimate of 13.00. The median estimate represents a +23.93% increase from the last price of 11.70.
The current consensus among 9 polled investment analysts is to Hold stock in Greenway Medical Technologies Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.